Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Wall Street
Price Targets
KNSA Price Targets Summary
Kiniksa Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for
KNSA
is 30.6 USD
with a low forecast of 28.28 USD and a high forecast of 33.6 USD.
KNSA Last Price Targets
Kiniksa Pharmaceuticals Ltd
The latest public price target was made on May 3, 2024 by
Eva Fortea Verdejo
from
Wells Fargo
,
who expects
KNSA
stock to
rise by 69%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Eva Fortea Verdejo
Wells Fargo
|
34
USD
Upside 69% |
1 day ago
May 3, 2024
|
Wells Fargo Starts Kiniksa (KNSA) at Overweight, 'we see +15-25% upside potential'
StreetInsider
|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is KNSA's stock price target?
Price Target
30.6
USD
According to Wall Street analysts, the average 1-year price target for
KNSA
is 30.6 USD
with a low forecast of 28.28 USD and a high forecast of 33.6 USD.
What is Kiniksa Pharmaceuticals Ltd's Revenue forecast?
Projected CAGR
33%
The
compound annual growth rate
of Kiniksa Pharmaceuticals Ltd's revenue for the next 3 years is
33%.
What is Kiniksa Pharmaceuticals Ltd's Net Income forecast?
Projected CAGR
-24%
The
compound annual growth rate
of Kiniksa Pharmaceuticals Ltd's net income for the next 3 years is
-24%.
You don't have any saved screeners yet
